scieee AI-readable full text Open interactive document viewer

Corrigendum to “The global threat of antimicrobial resistance: science for intervention” [New Microbes New Infect 6 (2015): 22–29]

Roca, I.; Akova, M.; Baquero, F.; Carlet, J.; Cavaleri, M.; Coenen, S.; López Cerero, Lorena; Rodríguez-Baño, Jesús; Vila, J.

Abstract

The authors would like to apologise for any inconvenience caused.

Full text

CORRIGENDUM Corrigendum to “The global threat of antimicrobial resistance: science for intervention”[New Microbes New Infect 6 (2015): 22–29] I. Roca 1 , M. Akova 2,25 , F. Baquero 3 , J. Carlet 4 , M. Cavaleri 5 , S. Coenen 6 , J. Cohen 7 , D. Findlay 8 , I. Gyssens 9 , O. E. Heuer 10 , G. Kahlmeter 11,25,26 , H. Kruse 12 , R. Laxminarayan 13,14 , E. Liébana 15 , L. López-Cerero 16 , A. MacGowan 17,26 , M. Martins 18 , J. Rodríguez-Baño 19,25 , J.-M. Rolain 20 , C. Segovia 21 , B. Sigauque 22 , E. Tacconelli 23,25 , E. Wellington 24 and J. Vila 1,25 1) ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic—Universitat de Barcelona, Barcelona, Spain, 2) Department of Medicine, Section of Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey, 3) Department of Microbiology at the Ramón y Cajal University Hospital, Ramón y Cajal Institute for Health Research (IRYCIS), Division for Research in Microbial Biology and Evolution, CIBERESP, Madrid, Spain, 4) Fondation Hôpital St, Joseph, Paris, France and World Alliance Against Antibiotic Resistance (WAAAR), Creteil, France, 5) European Medicines Agency (EMA), London, UK, 6) Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium, 7) Brighton and Sussex Medical School, Brighton, 8) Global Commercial Lead, GlaxoSmithKline (GSK), London, UK, 9) Department of Medicine, Radboud University Medical Center and Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands, 10) European Centre for Disease Prevention and Control (ECDC), Stockholm, 11) Clinical Microbiology, Central Hospital, Växjö, Sweden, 12) WHO Regional Office for Europe, UN City, Marmorvej, Copenhagen, Denmark, 13) Center for Disease Dynamics, Economics and Policy, Washington, DC, 14) Princeton University, Princeton, NJ, USA, 15) Scientific Unit on Biological Hazards, European Food Safety Authority (EFSA), Parma, Italy, 16) Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain, 17) Department of Medical Microbiology, Southmead Hospital, Bristol, UK, 18) School of Public Health, Physiotherapy and Population Science, UCD Centre for Food and Safety, Molecular Innovation and Drug Discovery, University College Dublin, Dublin, Ireland, 19) Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, and Departamento de Medicina, Universidad de Sevilla, Seville, Spain, 20) Aix-Marseille Université, Unité de Recherche en Maladies Infectieuses et Tropicales Emergentes (URMITE), Inserm, IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, and APHM, CHU Timone, Pôle Infectieux, Marseille, France, 21) Instituto de Salud Carlos III, ISCIII, Madrid, Spain, 22) Centro de Investigação em Saúde da Manhiça and Instituto Nacional de Saúde/Ministério de Saúde, Maputo, Mozambique, 23) Division of Infectious Diseases, Department of Internal Medicine I, Tübingen University Hospital, Tübingen, Germany, 24) School of Life Sciences, University of Warwick, Coventry, UK, 25) ESCMID Executive Committee, Basel, Switzerland and 26) EUCAST Steering Committee, Växjö, Sweden Corresponding author: J. Vila, Department of Clinical Microbiology, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain E-mail: [email protected] The authors regret that the spelling of author ‘O.E. Heuer’was initially misspelt as ‘Heure’in the published article. The authors regret that the spelling of author ‘E. Tacconelli’was initially misspelt as ‘Taconelli’in the published article. The authors would like to apologise for any inconvenience caused. New Microbe and New Infect 2015; 8: 175 New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) http://dx.doi.org/10.1016/j.nmni.2015.09.004 DOI of original article: http://dx.doi.org/10.1016/j.nmni.2015.02.007